Amid the worst public health emergency in a lifetime, UF Health leaders have taken steps to speed novel coronavirus research, recognizing the urgent need to provide answers and options to the communities they serve. In April, the CTSI and the Office of the Senior Vice President for Health Affairs created a $2 million pilot research fund for scientists with translational projects that can be rapidly mobilized. The RFA drew unprecedented interest from research teams and resulted in projects spanning colleges and the translational spectrum, all focused on a single, urgent issue. Read more about individual projects in the stories and news releases linked below, and watch recordings of online seminars given by awardees.
This RFA was designed to support projects that could be accomplished in six months or less and would contribute new knowledge that could inform the COVID-19 response and/or lay critical groundwork for subsequent research while extramural funding opportunities emerged.
The CTSI COVID-19 Task Force supports the rapid-response pilot awards.
Assistant Professor of Surgery on the acute care surgery team, UF Health, Department of Surgery
Associate Professor, Institute for Therapeutic Innovation
Associate Professor, Department of Pharmacotherapy and Translational Research
Louis and Marge Atkins Endowed Professor, Distinguished Professor, Department of Oral Biology, Associate Dean for Research
Professor, Department of Public Relations, Division of Hematology & Oncology, College of Medicine, Member, UF Health Cancer Center
Professor, Department of Neuroscience, Investigator, CTRND and McKnight Brain Institute
Associate Professor, Department of Pharmacotherapy & Translational Research
Professor & Chief Research Information Officer, Department of Health Outcomes & Biomedical Informatics
Professor of Medicine, Medical Director of the Thoracic Oncology Program, Director of the Lung Cancer Center, Division of Hematology & Oncology
Post-Doctoral Associate, McKnight Brain Institute, Department of Clinical Health & Health Psychology
Associate Professor, Integra LifeSciences Term Professor, Graduate Coordinator, Department of Biomedical Engineering
Assistant Professor, Department of Environmental & Global Health
Associate Professor, Vice Chair Of Research, Department of Emergency Medicine
Professor of Immunology, Department of Infectious Diseases & Pathology, Emerging Pathogens Institute
Assistant Professor, Department of Physiological Sciences
Post-Doctoral Associate, Department of Clinical & Health Psychology, Center for the Study of Emotion and Attention
Ebaugh Professor, Department of Mechanical & Aerospace Engineering
Assistant Professor, Departments of Neurosurgery and Pediatrics, Principal Investigator of the RNA Engineering Laboratory, Preston A. Wells, Jr. Center for Brain Tumor Therapy, UF Brain Tumor Immunotherapy Program
Professor, Department of Physiological Sciences
The Translational Science of COVID-19 Seminar Series features UF investigators funded by the Rapid-Response Translational Research Projects to Address COVID-19 Pandemic pilot program.
News and Updates
Local first responders and emergency room employees who do not have symptoms of the novel coronavirus but nonetheless worry they have been exposed to it can now receive testing at University of Florida. Health.
A new University of Florida study aims to gain a better understanding of the role children play in community transmission of COVID-19.
University of Florida Health researcher Mark Brantly, M.D., and his team are working to evaluate a drug treatment for the novel coronavirus that might block the deadly inflammatory response caused by the disease that curtails the lungs’ ability to function.
A new study by University of Florida researchers aims to identify a drug or drugs that can potentially be used to prevent and/or treat infection with COVID-19 by interfering with a known behavior of the virus — the way it binds to its cellular receptor, facilitating transmission to the respiratory system.
For UF researchers, pausing and resuming work brought challenges and sparked creativity as hundreds of teams across campus took aim at COVID-19.
All Pilot Project Awardees
|Scott Brakenridge, MD, MSCS||Medicine||Surgery||Immunophenotyping the COVID-19 Hospitalized Patients|
|Ashley Brown, PhD||Medicine||Medicine||Identification of effective antivirals against SARS-CoV-2|
|Jürgen Bulitta, PhD||Pharmacy||Pharmacotherapy||Developing innovative therapeutic strategies to combating Sars-CoV-2|
|Robert Burne, PhD||Dentistry||Oral Biology||Antiviral Potential of Commensal Streptococci|
|Carma Bylund, PhD||Journalism | Medicine||Public Relations | Hematology/Oncology||Doctor-Patient Cancer Communications through Telemedicine during COVID-19|
|Benoit Giasson, PhD||Medicine||Neuroscience||Novel antibodies to the SARS-CoV-2 spike protein for therapeutic targeting|
|Yan Gong, PhD||Pharmacy||Pharmacotherapy & Translational Research||Genomics and Pharmacogenomics of susceptibility and severity of COVID-19 in the UK Biobank|
|Christopher Harle, PhD||Medicine||Health Outcomes & Biomedical Informatics||Rapid Development of Pandemic Models for Actionable Clinical and Administrative Decision Support|
|Frederic Kaye, MD||Medicine||Hematology & Oncology||Randomized trial of bicalutamide to block TMPRSS2 in males with COVID-19 infection|
|David Marra, PhD||Public Health & Health Professions||Clinical & Health Psychology||Investigating Prevalence and Impact of Neurologic Manifestation in COVID-19 Positive Patients:A OneFlorida Research Consortium Study|
|Peter McFetridge, PhD||Engineering||Biomedical Engineering||A Novel Approach to Induce Rapid Healing, and Minimize Proinflammatory Responses in Covid-19 critical care patients: A pilot stud|
|Sarah McKune, PhD||Public Health & Health Professions||Environmental & Global Health||Characterization of COVID-19 Infection and Family Resilience in Symptomatic and Asymptomatic School-Age Children|
|Lisa Merck, MD||Medicine||Emergency Medicine||Epidemiology of COVID-19 in First Responders|
|David Pascual, PhD||Veterinary Medicine||Infectious Diseases & Pathology||Mucosal Subunit Vaccines for SARS-CoV-2|
|Leah Reznikov, PhD||Veterinary Medicine||Physiological Sciences||Targeted disruption of ACE2-SARS-CoV-2 interactions using small molecules|
|Nicola Sambuco, PhD||Public Health & Health Professions||Clinical & Health Psychology||Exposure to COVID-19 trauma and risk factors for developing psychopathology|
|Gregory Sawyer, PhD||Engineering||Mechanical & Aerospace Engineering||CLEARED: Culture of Living-biopsies for Emerging Airway-pathogens and REspiratory Disease (3D printing of lungs and SARS-Cov2)|
|Elias Sayour, MD, PhD||Medicine||Neurosurgery||Nanoparticle vaccines targeting SARS CoV 2|
|Christopher Vulpe, MD, PhD||Veterinary Medicine||Physiological Sciences||Identification of host determinants of SARS-CoV-2 infection|